US Supreme Court to hear Vermont IMS Health data-mining case
This article was originally published in SRA
The US Supreme Court has agreed to decide on the constitutionality of a state law that restricts the sale or use of prescription data for marketing purposes1,2. No patient-identifiable data are involved in the case, but Vermont's Prescription Confidentiality Law requires that a doctor must consent to the use of the data before they can be used for marketing purposes.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.